Identifying Treatment Resistance Related Pathways by Analyzing Serum Extracellular Vesicles of Patients With Resistant Versus Regressed Retinoblastoma-Reference-Cited by-同舟云学术

Identifying Treatment Resistance Related Pathways by Analyzing Serum Extracellular Vesicles of Patients With Resistant Versus Regressed Retinoblastoma

Published:2023-08-21 Issue:11 Volume:64 Page:26
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Manukonda Radhika¹²,Jakati Saumya³⁴,Attem Jyothi⁵,Mishra Dilip K.³,Mocherla Tirupathi Rao⁴,Reddy Mamatha M.⁶,Gulati Khushboo¹²,Poluri Krishna Mohan⁷,Vemuganti Geeta K.⁵,Kaliki Swathi¹

Affiliation:

1. The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, Telangana, India

2. Brien Holden Eye Research Center, L V Prasad Eye Institute, Hyderabad, Telangana, India

3. Ophthalmic Pathology Laboratory, L V Prasad Eye Institute, Hyderabad, Telangana, India

4. Prof. Krothapalli Ravindranath Ophthalmic Research Biorepository, L V Prasad Eye Institute, Hyderabad, Telangana, India

5. School of Medical Sciences, Science Complex, University of Hyderabad, Hyderabad, Telangana, India

6. The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Bhubaneswar, Odisha, India

7. Department of Biosciences and Bioengineering and Centre for Nanotechnology, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand, India

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

Cardiology and Cardiovascular Medicine

Reference46 articles.

1. Bilateral advanced (group D or E) intraocular retinoblastoma: outcomes in 72 Asian Indian patients;Kaliki;Eye (Lond),2019

2. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma;Shields;Arch Ophthalmol,2002

3. The International Classification of Retinoblastoma predicts chemoreduction success;Shields;Ophthalmology,2006

4. Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein;Chan;Cancer Res,1997

5. The FoxM1-ABCC4 axis mediates carboplatin resistance in human retinoblastoma Y-79 cells;Zhu;Acta Biochim Biophys Sin (Shanghai),2018